Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide Cognitive Effects in Partial Epilepsy
NCT01175954Phase 4Completed
- Sponsor
- Evan Fertig
- Start
- May 2010
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lacosamide in partial epilepsy, sponsored by Evan Fertig. Primary endpoint: Changes in Cognitive test scores at 30 weeks. Started May 2010; status: completed.
02
Drugs
lacosamide
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT01175954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175954.